Mol. Immunol.
Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB/c mice.
Kardani K, Hashemi A, Bolhassani A
A licensed vaccine against human immunodeficiency virus-1 (HIV-1) infection has not become available up to now. Hence, it is more rational to use immu ...
Read More
Source: PubMed
Aten Primaria 2020 Jan 29
[Where are the women in HIV/AIDS prevention campaigns in Spain? The importance of the gender perspective and affective-sexual diversity].
Obón-Azuara B, Gasch-Gallén Á, Gutiérrez-Cía I, Tomás-Aznar C
Read More
Source: PubMed
Infect. Genet. Evol. 2020 Jan 29
The impact of bone marrow stromal antigen-2 (BST2) gene variants on HIV-1 control in black South African individuals.
Dias BDC, Paximadis M, Martinson N, Chaisson RE, Ebrahim O, Tiemessen CT
Bone marrow stromal cell antigen 2 (BST2 or tetherin) is a host-encoded, interferon-inducible antiviral restriction factor which blocks the release of ...
Read More
Source: PubMed
J Pharm Sci 2020 Jan 29
Integration of computational and experimental approaches to elucidate mechanisms of first-pass lymphatic drug sequestration and long-acting pharmacokinetics of the injectable triple-HIV drug combination TLC-ART 101.
Perazzolo S, Shireman LM, McConnachie LA, Koehn J, Kinman L, Lee W, Lane S, Collier AC, Shen DD, Ho RJY
TLC-ART101 is a long-acting triple-HIV drug combination of lopinavir-ritonavir-tenofovir combined in one nano-suspension intended for subcutaneous inj ...
Read More
Source: PubMed
AIDS Behav 2020 Jan 31
Falling Through the Cracks: Risk Factors for Becoming Lost to HIV Care After Incarceration in a Southern Jail.
Tiruneh YM, Li X, Bovell-Ammon B, Iroh P, Flanigan TP, Montague BT, Rich JD, Nijhawan AE
Using a retrospective cohort analysis of inmates released from Dallas County Jail between January 2011 and November 2013, this study characterizes peo ...
Read More
Source: PubMed
